The Effect of Dietary Casein on the Induction of Lung Tumours by the Injection of 9,10-Dimethyl-1,2-Benzanthracene (DMBA) into Newborn Mice by Walters, Margaret A. & Roe, F. J. C.
312
THE EFFECT OF DIETARY CASEIN ON THE INDUCTION OF
LUNG TUMOURS BY THE INJECTION OF 9,10-DIMETHYL-
1,2-BENZANTHRACENE (DMBA) INTO NEWBORN MICE
MARGARET A. WALTERS AND F. J. C. ROE
From the Chester Beatty Research Institute, Institute of Cancer Research:
Royal Cancer Hospital, Fulham Road, London, S.W.3
Received for publication March 24, 1964
THE induction of neoplasms by the injection of a chemical carcinogen subcu-
taneously into newborn mice was first reported by Pietra, Spencer and Shubik
(1959). The possibility of using the technique as a test for carcinogenesis was
discussed by Roe, Rowson and Salaman (1961) and the results of tests using
1,2-benzanthracene, 2-naphthylamine, 2-naphthylhydroxylamine and ethyl
methane sulphonate were reported by Roe, Mitchley and Walters (1963). The
first of a series of experiments designed to define more precisely the conditions
under which such tests should be carried out is reported in the present paper.
MATERIALS AND METHODS
Mice
BALB/c (Bittner agent free) mice of a line originally obtainied from Dr. H. B.
Andervont of the National (Cancer Institute, Bethesda, and maintained in this
Institute by brother-sister mating since 1952 were used. During the experiment
the mice were housed in metal cages and given water ad libitum. They were
vaccinated at about 8 weeks of age as a precaution against ectromelia.
Chemical agentts
9,10-dimethyl-1,2-benzanthracene (DMBA) was obtained from Roche Products
Ltd.; gelatine powder from British Drug Houses.
Preparation of DMBA for administration
DMBA was administered as a suspension in 3 per cent aqueous gelatine, which
was prepared by adding an acetone solution of the compound to aqueous gelatine
warmed to 56° C. The acetone was driven off in a stream of nitrogen while the
temperature was maintained at this level. The dose per mouse was 002 ml.
Diets
The diets were prepared in powder form from the raw materials, then, on each
day except Sundays, some was mixed with tap water to make a dough and fed to
the mice ad libitunt. Double the usual quantity was fed on Saturdays.DIETARY CASEIN AND TUMOUR INDUCTION 313
Formula of high casein diet:
Per cent
Casein . . . . . . . 25
Wheat flour (containing approx. 10% protein) . 62-5
"Bemax " Stabilized Wheat Germ (Vitamins Ltd.)
(containing Carbohydrates
Protein
Vitamins of B group
Manganese
Iron
Copper
Essential amino acids) . . 5
Calcium carbonate . . . . 05
Salt mixture (Glaxo Laboratories Ltd.)
(containing Sodium chloride
Calcium phosphate
Potassium citrate
Magnesium sulphate
Iron citrate
Potassium iodide
Sodium fluoride
Manganese sulphate
Cuprous iodide
Potassium alum
Zinc sulphate) . . . . 1
Arachis oil and vitamins A and D concentrate
(Vitamin A: 40,000 international units
Vitamin D: 4,000 international units) 6
N.B. Total dietary protein = approx. 31%
Formulae of low casein diets:
Per cent
Casein . . . . . . 15
Wheat flour . . . . . 72*5
" Bemax" . . 5
Calcium carbonate . . . . 0.5
Salt mixture . . . . . . 1
Arachis oil and vitamins A and D concentrate 6
N.B. Total dietary protein = approx. 22%
Casein . . . . . . . 10
Wheat flour . . . . . . 77-5
" Bemax" . . . . . 5
Calcium carbonate . . . . 0 5
Salt mixture . . . . . . 1
Arachis oil and vitamins A and D concentrate 6
N.B. Total dietary protein = approx. 18%
Observation
All animals were examined thoroughly once each week and more cursorily
each day when they were fed. They were weighed once in every 4 weeks. Mice
which were sick or which showed a sudden or severe loss of weight were killed
and examined carefully post mortem. The surfaces of the five lobes of the lung
were examined for adenomatous lesions. Representative lung tumours, doubtful
lung lesions and all lesions from other organs which were definitely or possibly
neoplastic were taken for histological section.
EXPERIMENTAL
Pregnant females were fed diets containing either 25 % or 15% casein (i.e.
31% and 22% protein diets, respectively) from about 10 days before parturition.
Newly born litters were allotted randomly into a DMBA-treated group, a solventMARGARET A. WALTERS AND F. J. C. ROE
control group and an untreated control group within each dietary group (Groups
1-3: high casein, and Groups 4-6: low casein). Groups 1 and 4 received
30 ,.ug. DMBA in 0-02 ml. aqueous gelatine as a single subcutaneous injection in the
interscapular region when less than 24 hours old. To reduce the risk ofleakage the
point ofpenetration ofthe skin was as remote as possible from the point ofdelivery
of the injected material: thus the needle was introduced close to the root of the
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FIG. 1.-Body weights in treated and control animals.
Group 1: high casein diet + DMBA.
Groups 2 and 3: high casein diet controls combined.
Group 4: low casein diet + DMBA.
Groups 5 and 6: low casein diet controls combined.
N.B. There was no real difference in mean body weights between the solvent and untreated
controls within each dietary group.
tail. Groups 2 and 5 were similarly injected with 0-02 ml. aqueous gelatine,
while Groups 3 and 6 remained untreated.
Litters were housed separately until weaning, at which time the mice were
numbered on the ears and rehoused in boxes of 4 to 6, according to group and sex.
After weaning, the level of casein in the low protein diet was reduced from 15 %
to 10%. The 10 % level proved to be adequate for mice of 3 to 4 weeks of age or
more, but not for younger ones. (In a previous trial in which a 10 % protein diet
was fed to lactating mothers, a large proportion of the sucklings died before
weaning, mainly through cannibalism.) The body weights ofmice in treated and
control groups fed high and low protein diets were similar throughout the experi-
ment (Fig. 1). Surviving mice were killed during the 40th week. The same post
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TABLE I. Results of Experiment
Number Average
(per cent) number
Number Number of survivors of lung AMice with other
of mice survivors bearing lung tumours per tumours including
<_Uroup Diet Other treatmeint weaned at 40 wks. tumours* survivor malignant lymphoma
l) 30 lig. DMBA/3% 36 26 26 (100) 30-8 r3-malignant
aqueous gelatine q lymphoma
High I-hepatoma
2> caseini 30/% aclueous gelatine 39 30 7 (28) 0-21 0
3J None 35 34 5 (14) 0*14 0
41 30 ,ug. DMBA/3% 41 36 36 (100) 20-5 r3-hepatoma
aqueous gelatine. 1-granulosa cell tu-
Low L mour of ovary
casein 3o% aqueous gelatine 37 37 6 (16) 0-18 0
None 46 45 14 (24) 0 31 0
* i.e. Pulmonary adenomas and adenocarcinomas visible on surfaces on lobes.
mortem procedure was followed as for mice which died or were killed during the
experiment.
The results are presented in Table I. A comparison of the mean number of
lung tumours in Group 1 and Group 4 gives a t value of 2-86; P < 0-01. It was
impossible to distinguish absolutely between benign and malignant tumours:
the histological sections showed a graduation from one type to the other. It is
concluded that DMBA induces significantly more lung tumours in mice on a high
caseiin diet than in those on a low casein diet.
DISCUSSION
In previous experiments the modification of carcinogenesis by changes in
dietary protein has been unequivocally demonstrated in the case of liver tumours
only. Tannenbaum and Silverstone (1949) reported a strikingly low incidence of
spontaneously " occurring hepatomas in mice fed a diet containing only 9 %
casein compared with that in mice fed diets containing 18, 27, 36 or 45 % casein.
The difference was the same whether the animals were fed ad libitum or isocalori-
cally. A similar result was obtained in experiments in which caloric intakes were
controlled so as to maintain equivalent body weights among the several groups
(Silverstone and Tannenbaum, 1951). On the other hand, a high level of protein
in the diet causes a decreased tumour incidence and a lengthening of the latent
period in the induction of hepatomas in rats by feeding dimethylaminoazobenzene
(Miller, Miner, Rusch and Baumann, 1941 ; Silverstone, 1948; Elson, 1958).
Carcinogenesis has been uninfluenced by varying the proportion of casein from
9) to 45 % in experiments involving three other types of tumours. The rate of
formation of spontaneous mammary carcinomata and the incidence and rate of
appearance of benzopyrene-induced skin tumours did not vary in groups of mice
fed ad libitum diets containing 9, 18, 27, 36 or 45 % casein (Tannenbaum and Silver-
stone, 1949). Neither was the induction of sarcomas by carcinogenic hydro-
carbons modified by an increase in dietary casein from 18 to 32 % (Tannenbaum
and Silverstone, 1949), nor from 13 to 26 % in diets fed ad libiturn or 20 to 40 %
in calorie-restricted rations (Rusch, Johnson and Kline, 1945). However,
Tannenbaum and Silverstone (1953) suggested that with a less potent carcinogenic
stimulus a small but significant effect would be seen. This seems to be true in
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experiments in which mice are injected with carcinogen within 24 hours ofbirth
where a high level protein diet favours high tumour incidence.
SUMMARY
Mice injected within 24 hours ofbirth with 30 ,ug. DMBA in 0 02 ml. 3 per cent
aqueous gelatine and fed a high casein diet (25 % casein) developed significantly
more lung tumours than mice similarly injected but fed a low casein diet (15%o
reducing to 10 % casein).
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